Ghada El-Hajj Fuleihan, MD, MPH, FRCP
Professor of Medicine & Physician-Scientist, American University of Beirut, Lebanon
Ghada El-Hajj Fuleihan, MD, MPH, FRCP is Professor of Medicine, Physician-Scientist, at the American University of Beirut (AUB), Beirut, Lebanon. She is founding director of the Calcium Metabolism and Osteoporosis Program, World Health Organization (WHO) Collaborating Center for Metabolic Bone Disorders, and of the Scholars in HeAlth Research Program at AUB.
Dr El-Hajj Fuleihan obtained her medical degree from AUB, completed residency and fellowship training at the New England Deaconess and Brigham and Women’s Hospital (Harvard Medical School, Boston). She holds a master’s in Public Health (clinical effectiveness concentration) from the Harvard School of Public Health.
She is the PD/PI on multiple investigator-initiated grants, including the NIH D43 capacity-building grant, awarded a 5-year competitive renewal (2020-2025). Dr El-Hajj Fuleihan’s laboratory focuses on generating evidence on the pathophysiology, prevention, and treatment of hypovitaminosis D, osteoporosis, and other metabolic bone disorders. She leads a team that conducts clinical trials, systematic reviews, and meta-analyses, and translates findings into prevention and treatment strategies.
Dr El-Hajj Fuleihan closely collaborates with Ministry of Health officials and international experts to generate evidence-based national and international care pathways. She led the International Osteoporosis Foundation (IOF) Middle East Africa audit, and launched FRAX Lebanon, the first fracture risk calculator in the Middle East. She has mentored more than 64 postgraduate trainees and junior faculty.
She has published on her topics of interest in over 190 publications, mostly peer-reviewed original investigations, chapters, invited reviews, and penned several invited editorials, scientific position statements, and commentaries in the New England of Medicine, Journal of Clinical Endocrinology and Metabolism, and Nature Reviews Endocrinology.
Dr El-Hajj Fuleihan is a member of the Alpha Omega Alpha Medical Honor Society, and recipient of several awards. She currently serves a three-year term on the board of directors of the Endocrine Society, chairs its Clinical Practice Guidelines committee on Management of Hypercalcemia of Malignancy, co-chairs the International Task Force on Clinical Manifestations of Primary Hyperparathyroidism, is a member of the WHO Nutrition Expert panel, and currently serves on the Food and Agriculture Organization (FAO)-WHO expert group on nutrient requirements for children 0-36 months. She also holds a lifelong appointment as the Bernard Lown Scholar in the Department of Global Health and Population (Harvard T.H.Chan School of Public Health).
She joined the editorial board of Mayo Clinic Proceedings in 2022, bringing expertise in calcium metabolism and osteoporosis.